MASI DINA (Chief Financial Officer) received a stock award from INTEGRATED BIOPHARMA INC
Compensation award — not an open‑market transaction. Less informative as a directional signal.
A · 1 award
Filed: 11/25/2024ACC: 0001345281-24-000005
Officer· Chief Financial Officer
Since May 2019
0.00
Net shares
Net seller
$5.8K
Total acquired
0
Open market trades
0B · 0S
2
Total transactions
65K acquired · 65K disposed
Non-Derivative Transactions1
Common Stock
Direct
Shares
+65K
Price / share
$0.09
Trade value
$5.85K
% of position
44.2%
11/25/2024
147.20K→212.20K
Total
Net shares
+65K
Net value
$5.85K
| Security | Date | Type | Shares | Price / Share | Trade Value | % of Position | Held Before | Held After |
|---|---|---|---|---|---|---|---|---|
| Common Stock Direct | 11/25/2024 | A · Award | +65K | $0.09 | $5.85K | 44.2% | 147.20K | 212.20K |
| Total | +65K | $5.85K | ||||||
Derivative Transactions1
Stock Option (right to buy)
Direct
Converts to
Common Stock
65K shares
Shares
−65K
Strike price
0.09
Held after
135K
Exercisable
—
11/25/2024
| Security | Converts To | Date | Type | Shares | Strike Price | Exercisable | Held After |
|---|---|---|---|---|---|---|---|
| Stock Option (right to buy) Direct | Common Stock65K shares | 11/25/2024 | D · Disposition | −65K | 0.09 | — | 135K |